A phase 3 trial in pancreatic cancer, run by Fudan University, now recruiting.
Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer is a phase 3, randomised interventional study registered as NCT06250972 by Fudan University, with a registry enrolment figure of 210 participants, started 2024-05-15 and due to reach its primary completion in 2027-05-01. Interventions recorded: Gemcitabine, Nab-paclitaxel, Irinotecan; Intensity-Modulated Radiation Therapy (IMRT). Conditions listed: Pancreatic Adenocarcinoma. Primary outcome: progression-free survival, PFS. Pancreatic eligibility wording from the registry: "* Histologically or cytologically confirmed advanced pancreas adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, IMRT / IGRT (modern external beam) and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, IMRT / IGRT (modern external beam) and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, IMRT / IGRT (modern external beam) and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, IMRT / IGRT (modern external beam) and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, IMRT / IGRT (modern external beam) and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.